Funding for this research was provided by:
Marianne and Marcus Wallenberg Foundation (N/A)
Text and Data Mining valid from 2019-01-09
Received: 11 December 2018
Accepted: 11 December 2018
First Online: 9 January 2019
: KB and HZ are co-founders of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. KB has served as a consultant or at advisory boards for Alzheon, Eli Lilly, Fujirebio Europe, IBL International, Novartis and Roche Diagnostics. HZ has served at advisory boards of Eli Lilly and Roche Diagnostics and has received travel support from TEVA. SL is an employee of Johnson and Johnson.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.